[1]
|
Xia C.F., Dong, X.S., Li, H., et al. (2022) Cancer Statistics in China and United States, 2022: Profiles, Trends, and De-terminants. Chinese Medical Journal, 135, 584-590. https://doi.org/10.1097/CM9.0000000000002108
|
[2]
|
Siegel, R.L., Miller, K.D., Fuchs, H.E. and Jemal, A. (2022) Cancer Statistics, 2022. CA: A Cancer Journal for Clinicians, 72, 7-33. https://doi.org/10.3322/caac.21708
|
[3]
|
Cathomas, R., Lorch, A., Bruins, H.M., et al. (2022) The 2021 Up-dated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma. European Urology, 81, 95-103. https://doi.org/10.1016/j.eururo.2021.09.026
|
[4]
|
陈双双, 马锐. 多原发癌的研究进展[J]. 癌症进展, 2019, 17(8): 883-886.
|
[5]
|
Bruinsma, S.M., Bangma, C.H., Carroll, P.R., et al. (2016) Active Surveillance for Prostate Can-cer: A Narrative Review of Clinical Guidelines. Nature Reviews Urology, 13, 151-167. https://doi.org/10.1038/nrurol.2015.313
|
[6]
|
Qarro, A., Ammani, A., Bazine, K., Najoui, M., Samir, J. and Alami, M. (2014) Synchronous Primary Malignancies of the Male Urogenital Tract. Canadian Urological Association Journal, 8, E353-E355. https://doi.org/10.5489/cuaj.1532
|
[7]
|
Jing, Y., Zhang, R., Ma, P., Cai, M.-C., Zhuang, G. and Chen, H. (2018) Prevalence and Clonality of Synchronous Primary Carcinomas in the Bladder and Prostate. The Journal of Pathology, 244, 5-10.
https://doi.org/10.1002/path.4997
|
[8]
|
吴鹏飞, 郭长城, 姚旭东. 雄激素受体在膀胱癌中表达及价值——基于TCGA数据库分析[J]. 中国男科学杂志, 2018, 32(6): 38-41.
|
[9]
|
Izumi, K., Taguri, M., Miyamoto, H., et al. (2014) Androgen Deprivation Therapy Prevents Bladder Cancer Recurrence. Oncotarget, 5, 12665-12674. https://doi.org/10.18632/oncotarget.2851
|
[10]
|
娄诚, 杜智, 高英堂. 区域癌化及其临床意义[J]. 国际肿瘤学杂志, 2007, 34(10): 747-750.
|
[11]
|
Hayashi, T., Fujita, K., Hayashi, Y., et al. (2020) Mutational Landscape and Environ-mental Effects in Bladder Cancer. International Journal of Molecular Sciences, 21, Article No. 6072. https://doi.org/10.3390/ijms21176072
|
[12]
|
Thomas, C., Giesswein, A., Hainz, M., et al. (2015) Concomitant Gleason Score ≥7 Prostate Cancer Is an Independent Prognosticator for Poor Survival in Nonmetastatic Bladder Cancer Patients Undergoing Radical Cystoprostatectomy. International Urology and Nephrology, 47, 1789-1796. https://doi.org/10.1007/s11255-015-1110-1
|
[13]
|
Brookman-May, S.D., Campi, R., Henríquez, J.D.S., et al. (2019) Latest Evidence on the Impact of Smoking, Sports, and Sexual Activity as Modifiable Lifestyle Risk Factors for Prostate Cancer Incidence, Recurrence, and Progression: A Systematic Review of the Literature by the European Association of Urology Section of Oncological Urology (ESOU). European Urology Focus, 5, 756-787. https://doi.org/10.1016/j.euf.2018.02.007
|
[14]
|
Romaszko-Wojtowicz, A., Buciński, A. and Doboszyńska, A. (2018) Impact of Smoking on Multiple Primary Cancers Survival: A Retrospective Analysis. Clinical and Experimental Medi-cine, 18, 391-397.
https://doi.org/10.1007/s10238-018-0498-1
|
[15]
|
Moschini, M., Zaffuto, E., Karakiewicz, P.I., et al. (2019) External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Af-fected by Prostate Cancer: A Population-Based Analysis. European Urology, 75, 319-328. https://doi.org/10.1016/j.eururo.2018.09.034
|
[16]
|
Shiota, M., Yokomizo, A., Takeuchi, A., et al. (2015) Secondary Bladder Cancer after Anticancer Therapy for Prostate Cancer: Reduced Comorbidity after Androgen-Deprivation Therapy. Oncotarget, 6, 14710-14719.
https://doi.org/10.18632/oncotarget.3817
|
[17]
|
孙俊杰, 李双庆. 多原发癌病因及发病机制的探索[J]. 中国全科医学, 2017, 20(9): 1136-1141.
|
[18]
|
Lopez-Beltran, A., Cheng, L., Montorsi, F., et al. (2017) Concomitant Bladder Cancer and Prostate Cancer: Challenges and Controversies. Nature Reviews Urology, 14, 620-629. https://doi.org/10.1038/nrurol.2017.124
|
[19]
|
赵国栋, 刘士军, 胡浩. 前列腺偶发癌的临床分期及治疗方案与预后的相关性研究[J]. 临床和实验医学杂志, 2014, 13(12): 1014-1016.
|
[20]
|
Malte, R., Kluth, L.A., Kaushik, D., et al. (2017) Frequency and Prognostic Significance of Incidental Prostate Cancer at Radical Cystectomy: Results from an International Retrospective Study. European Journal of Surgical Oncology, 43, 2193-2199. https://doi.org/10.1016/j.ejso.2017.08.013
|
[21]
|
Pignot, G., Salomon, L., Neuzillet, Y., et al. (2014) Clinicopatho-logical Characteristics of Incidental Prostate Cancer Discovered from Radical Cystoprostatectomy Specimen: A Multi-center French Study. Annals of Surgical Oncology, 21, 684-690. https://doi.org/10.1245/s10434-013-3340-8
|
[22]
|
Jønck, S., Helgstrand, J.T., Røder, M.A., et al. (2018) The Prog-nostic Impact of Incidental Prostate Cancer Following Radical Cystoprostatectomy: A Nationwide Analysis. Scandinavi-an Journal of Urology, 52, 358-363.
https://doi.org/10.1080/21681805.2018.1534885
|
[23]
|
Fahmy, O., Khairul-Asri, M.G., Schubert, T., et al. (2017) Clinicopathological Features and Prognostic Value of Incidental Prostatic Adenocarcinoma in Radical Cystoprostatectomy Specimens: A Systematic Review and Meta-Analysis of 13,140 Patients. Journal of Urology, 197, 385-390. https://doi.org/10.1016/j.juro.2016.08.088
|
[24]
|
Buse, S., et al. (2013) Characterization and Risk Stratification of Prostate Cancer in Patients Undergoing Radical Cystoprostatectomy. International Journal of Urology, 20, 866-871. https://doi.org/10.1111/iju.12073
|
[25]
|
Kong, Y., Li, J., Lin, H., Liang, X. and Zhou, X. (2022) Landscapes of Synchronous Multiple Primary Cancers Detected by Next-Generation Sequencing. FEBS Open Bio, 12, 1996-2005. https://doi.org/10.1002/2211-5463.13491
|
[26]
|
Cavazos, T.B., Kachuri, L., Graff, R.E., et al. (2022) Assessment of Genetic Susceptibility to Multiple Primary Cancers through Whole-Exome Sequencing in Two Large Multi-Ancestry Studies. BMC Medicine, 20, Article No. 332.
https://doi.org/10.1186/s12916-022-02535-6
|